Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 70.25

+0.1%

Nov 6 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (116)	11/18/2002 11:06:25 PM
From: Jibacoa	Read Replies (1) of 3722

MDCC Was up 17.21% on volume of 499,125 ( about 4.9x its daily average), after an analyst at Deutsche Bank Securities upgraded it from "hold" to "buy".<g> According to the analyst,the company is due for a turnaround after the introduction of its Ion Works HT.(The company had announced that on September 18 and had a demonstration of this new system at the Society for Biomolecular Screening meeting on Sept. 23-26, in the Netherlands. siliconinvestor.com From a longer term view, the stock seems to have plenty of room to run.<g> siliconinvestor.com The stock earning's have remained on the black, with a PE around 37. It has been selling around 1.64 of book, has no LTD and about $3.30 cash/share. Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next